Literature DB >> 11390533

Prevalence and risk factors for anal squamous intraepithelial lesions in women.

E A Holly1, M L Ralston, T M Darragh, R M Greenblatt, N Jay, J M Palefsky.   

Abstract

BACKGROUND: Anal cancers are thought to arise from squamous intraepithelial lesions in the anal canal, and women infected with human immunodeficiency virus-1 (HIV) may be at higher risk of anal cancer. Our aim was to determine the prevalence of human papillomavirus (HPV)-related abnormalities of the anal canal in women and to characterize risk factors for these lesions.
METHODS: We evaluated HPV-related abnormalities in 251 HIV-positive and in 68 HIV-negative women. We completed physical examinations and obtained questionnaire data on medical history and relevant sexual practices. Univariate and adjusted relative risks (RRs) and 95% confidence intervals (CIs) were computed using the Mantel-Haenszel procedure and regression techniques. All statistical tests were two-sided.
RESULTS: Abnormal anal cytology, including atypical squamous cells of undetermined significance, low-grade squamous intraepithelial lesions, or high-grade squamous intraepithelial lesions (HSILs), was diagnosed in 26% of HIV-positive and in 8% of HIV-negative women. HSILs were detected by histology or cytology in 6% of HIV-positive and in 2% of HIV-negative women. HIV-positive women showed increased risk of anal disease as the CD4 count decreased (P<.0001) and as the plasma HIV RNA viral load increased (P =.02). HIV-positive women with abnormal cervical cytology had an increased risk of abnormal anal cytology at the same visit (RR = 2.2; 95% CI = 1.4 to 3.3). Abnormal anal cytology in HIV-positive women was associated with anal HPV RNA detected by the polymerase chain reaction and by a nonamplification-based test (RR = 4.3; 95% CI = 1.6 to 11). In a multivariate analysis, the history of anal intercourse and concurrent abnormal cervical cytology also were statistically significantly (P =.05) associated with abnormal anal cytology.
CONCLUSIONS: HIV-positive women had a higher risk of abnormal anal cytology than did HIV-negative women with high-risk lifestyle factors. These data provide strong support for anoscopic and histologic assessment and careful follow-up of women with abnormal anal lesions.

Entities:  

Mesh:

Year:  2001        PMID: 11390533     DOI: 10.1093/jnci/93.11.843

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  55 in total

1.  [Anal HPV infections].

Authors:  Felix Aigner; Friedrich Conrad; Andreas Widschwendter; Robert Zangerle; Bettina Zelger; Alfred Haidenberger; Sebastian Roka; Kurt Heim; Reinhard Höpfl; Martin Klimpfinger; Yves Marcus Rigler; Hugo Bonatti; Johann Pfeifer; Andrea Maier; Reinhard Kirnbauer; Andreas Salat
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

2.  Human papillomavirus, condylomata acuminata, and anal neoplasia.

Authors:  George J Chang; Mark L Welton
Journal:  Clin Colon Rectal Surg       Date:  2004-11

3.  Description of a pilot anal pap smear screening program among individuals attending a Veteran's Affairs HIV clinic.

Authors:  Isabella Rosa-Cunha; Vincent A Degennaro; Rene Hartmann; Clara Milikowski; Andres Irizarry; Brenda Heitman; Orlando Gómez-Marín; Gordon M Dickinson
Journal:  AIDS Patient Care STDS       Date:  2011-03-02       Impact factor: 5.078

4.  The role of Human Papilloma Virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infection.

Authors:  Luis F Barroso
Journal:  Ther Adv Vaccines       Date:  2013-07

5.  Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women.

Authors:  Nancy A Hessol; Elizabeth A Holly; Jimmy T Efird; Howard Minkoff; Kathleen M Weber; Teresa M Darragh; Robert D Burk; Howard D Strickler; Ruth M Greenblatt; Joel M Palefsky
Journal:  AIDS       Date:  2013-07-17       Impact factor: 4.177

6.  CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women.

Authors:  Hung N Luu; E Susan Amirian; Wenyaw Chan; R Palmer Beasley; Linda B Piller; Michael E Scheurer
Journal:  J Infect Dis       Date:  2012-01-13       Impact factor: 5.226

7.  Sociodemographic Predictors of Anal Cancer Screening and Follow-up in Human Immunodeficiency Virus-Infected Individuals.

Authors:  Jessica S Wells; Marcia M Holstad; Deborah Watkins Bruner
Journal:  Cancer Nurs       Date:  2018 Sep/Oct       Impact factor: 2.592

8.  Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women.

Authors:  Nancy A Hessol; Elizabeth A Holly; Jimmy T Efird; Howard Minkoff; Karlene Schowalter; Teresa M Darragh; Robert D Burk; Howard D Strickler; Ruth M Greenblatt; Joel M Palefsky
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

9.  Association between smoking and size of anal warts in HIV-infected women.

Authors:  H N Luu; E S Amirian; R P Beasley; L Piller; W Chan; M E Scheurer
Journal:  Int J STD AIDS       Date:  2012-11       Impact factor: 1.359

Review 10.  [Impact of prophylactic HPV vaccines on dermatology and venereology].

Authors:  G Gross
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.